Current Affairs is Back

-
Image
  Greetings! After long time, we are back with the current affairs. Sorry for the long time gap due to the numbers of reasons.  We wish the same supports here after.  We are back in 2021................. We believe in you and hope that you will support as before .............Here will be more exciting news and views................. Thanks............
Post a Comment

CHINA Started First Mass Production of COVID-19 Vaccine

-

 

Vaccine against CORONA

 

CHINA

Started First  Mass Production

of

COVID-19 Vaccine

 


A vaccine factory in China has qualified to mass produce a COVID-19 vaccine. In a press release on Wednesday, China National Biotech Group said that in mid-July its world's first inactivated COVID-19 vaccine production plant in Beijing passed joint bio-safety inspections organized by relevant departments, and is qualified to put a vaccine into mass production at any time. Previously, the production facility had obtained a COVID-19 vaccine production license.

China made breakthrough in battling the Corona Virus pandemic, with China National Biotec Group CNBG announced that an inactivated COVID-19 vaccine production workshop of its affiliated Beijing institute of biological products, the first and largest of its kind in the world, has passed national examination. The facility was granted a production certificate and it is now available for use, CNBG, an affiliate of the state-run China National Pharmaceutical Group, said in a statement sent to the Global Times.  The Beijing institute took only two months to finish building the facility on April 15. Related government departments conducted a thorough bio-security examination of the production workshop in July, and concluded the facility met national standards, and could go into operation for mass production of COVID-19 vaccines, read the statement. After the Beijing manufacturing workshop and another production facility belonging to CNBG's Wuhan institute of biological products begin operations, CNBG will be capable of ensuring an annual capacity of 220 million doses of vaccines, according to its developer. These millions of doses are large to first immunize medical staff and personnel working at airports and border checkpoints, Tao Lina, a Shanghai-based vaccine researcher mentioned.
"It is possible that China could have a COVID-19 vaccine as early as the end of October as some domestically made COVID-19 vaccines have entered phase three clinical trials and needs about a month to observe their effects on samples," Tao said. After securing a certain amount of vaccine for China's strategic reserves, exports can be considered, Tao noted, adding countries such as the Philippines and Brazil are potential destinations. Sinopharm is launching the fourth major COVID-19 vaccine trial in Brazil and will seek regulatory approval soon, Reuters reported. The company's candidate vaccine is already being tested in the United Arab Emirates with 15,000 local volunteers, including UAE nationals and expatriates there, since middle July. In another major step, German firm BioNTech and its Chinese partner Shanghai Fosun Pharmaceutical announced Wednesday that 72 trial participants have been dosed with BNT162b1, a COVID-19 vaccine candidate based on BioNTech's mRNA technology, following the Chinese regulators' examination and approval. The two firms are jointly developing the coronavirus vaccine candidate in China too.

In another sign of progress, scientists from the Hong Kong and Macao special administrative regions announced Monday a breakthrough in the development of a recombinant COVID-19 vaccine, envisioning the vaccine's mass production to be feasible at a low cost in the future. A spokesperson for Ministry of Industry and Information Technology said in late July that China has 13 firms that have begun capacity building for COVID-19 vaccines, and nine have been approved to start clinical trials. Four of the nine firms are pushing for an inactivated vaccine technical route, three are focusing on nucleic acid vaccines, one is based on adenovirus vector vaccines and one has opted for recombinant protein vaccines, media reports say. The nation's advances in the research and manufacture of COVID-19 vaccines have been translated into remarkable gains in vaccine-related stocks on the A-share market.  CanSino Biologics revealed in late June that a recombinant novel COVID-19 vaccine it developed with a military research team has been granted a special one-year military drug approval………………..


----CGTN & International Agencies

Comments

Post a Comment

Popular posts from this blog

The 2020 AA WAR

-
Image
  THE 2020 ARMENIA- AZERBAIJAN WAR (AA WAR) Image:  https://en.wikipedia.org/wiki/Nagorno-Karabakh_conflict The COVID-19 pandemic continues throughout the world and the people of the Armenia and Azerbaijan are in panic state. This is not only because of the COVID-19 pandemic. The circumstances of people of these nations are worsening because of the conflict between these two nations at Nagorno-Karabakh vicinity and surroundings. The war casualties may be more than death caused by this pandemic.  Also Read : How Does COVID -19 Pandemics End? This started on the morning of September 27, 2020, since when every country has claimed to have inflicted serious loss on its opponent. What’s different about the present day flare-up is that this is the first time that both nations have proclaimed martial law. According to the Warsaw-based Centre for Eastern Studies , the cutting-edge escalation used to be most likely initiated by Azerbaijan. Media reports have referred to that ...
Read more

The Chernobyl: Then and Now

-
Image
Ghost Town Series :   The Chernobyl: Then and Now The Chernobyl Power plant designed graphite-moderated nuclear power 1K nuclear reactors, a design that is now universally recognized as inherently flawed. The reactors had been of a pressure tube design that used an enriched uranium dioxide gasoline to heat water, creating steam that drives the reactors' turbines and generates electricity, in accordance to the World Nuclear Association. In most nuclear reactors, water is additionally used as a coolant and to average the reactivity of the nuclear core by removing the excess heat and steam. But, the reactors used graphite to moderate the core's reactivity and to hold a non-stop nuclear reaction taking place in the core. As the nuclear core heated and produced more steam bubbles, the core became more reactive, developing a positive-feedback loop that engineers refer to as a "positive-void coefficient." The explosion occurred on April 26, 1986, during a routine maintenan...
Read more

Possible Post COVID-19 Economic Condition

-
Image
Possible Post-COVID-19 Economic Condition   Corona Virus Diseases (COVID-19) pandemic, and the world recession it has triggered, are of route inflicting sizeable human struggling round the world.   We should face years of depressed and disrupted monetary growth.   Those who go through most will be the much less outfitted to respond.   Extreme poverty and starvation are set to amplify drastically. Health-service structures in many nations are already at breaking factor and a era of adolescents is lacking out on their education. The pandemic threatens now not simply to put the 2030 Agenda for Sustainable Development on hold, however to reverse development that has already been made. The crisis has been calling for a rescue bundle amounting to at least 10 per cent of the international economy. It is fascinating to see that developed nations are essentially doing it with their personal assets or printing cash when their currencies can be customary in all occasions ...
Read more